China has taken a series of actions in the past week on counter-narcotics, in a sign of cooperation with U.S. demands for ...

Historic changes are afoot for pharma as China gains ground on U.S. production. The pharma industry is projected to see ...

President Trump has threatened to impose pharma tariffs to encourage investment in U.S. manufacturing, but experts say there could be unintended consequences.

In May, Pfizer spent $1.25 billion upfront for the right to license an experimental cancer drug from China's 3SBio. That is ...

Supply-chain decoupling doesn’t stop rival nations from hacking each other and can make it worse. A cyber-espionage expert ...

Healthcare leaders are navigating the new era of trade policy following a series of tariffs recently imposed by President Donald Trump. Here are six takeaways on where tariffs stand now: ...

The Trump administration plans new tariffs. These tariffs target sectors vital to national security. Semiconductors and ...

Here are the key issues at play: India's dependence on agriculture - a major source of rural jobs - has made it politically ...

It looks like U.S. pharmaceutical companies are looking to China for drugs. U.S. drugmakers are licensing molecules from ...

Amid escalating U.S.-China trade tensions, top Chinese drug research firms like WuXi AppTec and WuXi Biologics (HK:2269) are ...

The remarks suggest that Brussels could – like the UK – accept a 10% levy on most European exports in order to avoid ...

UK Prime Minister Keir Starmer and US President Donald Trump announced they had inked the deal at the Group of Seven Summit.